iBio, Inc. (IBIO)
NASDAQ·Healthcare·Biotechnology
$1.70
+1.50%
Mkt Cap $27.00M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (2 analysts)
$2.80
Range $2.00 – $3.60
Implied Upside
+65.2%
Consensus $2.80 vs current $1.70
NASDAQ·Healthcare·Biotechnology
$1.70
+1.50%
Mkt Cap $27.00M
Buy
3
Hold
0
Sell
0
Price Target (2 analysts)
$2.80
Range $2.00 – $3.60
+65.2%
Consensus $2.80 vs current $1.70